1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
(
- Contribution to journal › Article
-
Mark
prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk.
(
- Contribution to journal › Article
- 2011
-
Mark
Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels.
(
- Contribution to journal › Article
- 2010
-
Mark
Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females - relation to age, gonadotrophin and steroid levels
2010) 26th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology In Human Reproduction 25. p.298-298(
- Contribution to journal › Published meeting abstract
-
Mark
Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays
(
- Contribution to journal › Article
-
Mark
Impact of Recent Screening on Predicting the Outcome of Prostate Cancer Biopsy in Men With Elevated Prostate-Specific Antigen Data From the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden
(
- Contribution to journal › Article
-
Mark
C-peptide in dried blood spots.
(
- Contribution to journal › Article
-
Mark
Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays.
(
- Contribution to journal › Article
- 2008
-
Mark
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
(
- Contribution to journal › Article